Research shows that petrolatum-based eye ointments can cause the device to swell and potentially rupture, prompting an urgent update to clinical guidance Widely-used eye ointments can cause glaucoma ...

—AZR-MD-001 is a Potential First-in-Class Therapy Targeting Meibomian Gland Dysfunction (MGD), the Root Cause of Dry Eye Disease (DED) and Contact Lens Discomfort (CLD)— "We are very encouraged by the ...

—AZR-MD-001 is a Potential First-in-Class Therapy Targeting Meibomian Gland Dysfunction (MGD), the Root Cause of Dry Eye Disease (DED) and Contact Lens Discomfort (CLD)— TEL AVIV, Israel--(BUSINESS ...

A new West Virginia law overturns a long-standing mandate that medical professionals treat newborns’ eyes with an ointment meant to prevent pink eye or potentially blindness if the baby comes into ...

Introduction: Information regarding the impact of topical antibiotics with or without corticosteroids on the microbiota of the horses’ eyes is limited. This study aimed to describe the bacterial ...

As the pharmaceutical industry increasingly focuses on developing targeted treatments for niche conditions, Viatris Inc. (NASDAQ:VTRS) on Friday announced topline data from a Phase 3 study evaluating ...

July 18 (Reuters) - Viatris (VTRS.O), opens new tab said on Friday that its experimental eye ointment failed to clear buildup or debris in the eyes in a late-stage study in patients with an ...

Treatment with pimecrolimus 0.3% ophthalmic ointment did not significantly improve blepharitis compared with placebo. Topline data were announced from a phase 3 trial evaluating pimecrolimus 0.3% ...

The list of possible suspects seemed long. By Shawn McCreesh Reporting from Washington It was like metaphor turned reality. After 130 days spent fighting the federal government, Elon Musk turned up ...

If you suffer from dry or itchy eyes, listen up: more than 75,000 cases of eye drop solution were voluntarily recalled nationwide by BRS Analytical Service, a pharmaceutical testing lab, according to ...

Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — Nordic Pharma and Harrow partnered to launch an authorized generic of Maxitrol, Nordic President ...

BERWYN, Pa., April 24, 2025 /PRNewswire/ -- Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., announced a partnership with Harrow (Nasdaq: HROW), a leading North American eyecare company, to ...